A randomized and open-label phase I clinical study registered with ClinicalTrials.gov #NCT 01268787 , aims to evaluate the safety , reactogenicity and immunogenicity of a formalin-inactivated EV71 vaccine candidate ( EV71vac ) at 5 - and 10-g doses .